These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 8434657)

  • 1. Organic mood syndrome associated with detoxification from methadone maintenance.
    Kanof PD; Aronson MJ; Ness R
    Am J Psychiatry; 1993 Mar; 150(3):423-8. PubMed ID: 8434657
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of the withdrawal responses of heroin and methadone addicts during detoxification.
    Gossop M; Strang J
    Br J Psychiatry; 1991 May; 158():697-9. PubMed ID: 1860023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The acute effects of a rapid medical detoxification upon dysphoria and other psychopathology experienced by heroin abusers.
    Ness R; Handelsman L; Aronson MJ; Hershkowitz A; Kanof PD
    J Nerv Ment Dis; 1994 Jun; 182(6):353-9. PubMed ID: 8201308
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The dysphoria of heroin addiction.
    Handelsman L; Aronson MJ; Ness R; Cochrane KJ; Kanof PD
    Am J Drug Alcohol Abuse; 1992; 18(3):275-87. PubMed ID: 1329491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patterns of symptom complaints in methadone maintenance patients.
    Dyer KR; White JM
    Addiction; 1997 Nov; 92(11):1445-55. PubMed ID: 9519488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence and diagnostic reliability of methadone maintenance detoxification fear.
    Milby JB; Gurwitch RH; Wiebe DJ; Ling W; McLellan AT; Woody GE
    Am J Psychiatry; 1986 Jun; 143(6):739-43. PubMed ID: 3717396
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Subjective and physiological responses among racemic-methadone maintenance patients in relation to relative (S)- vs. (R)-methadone exposure.
    Mitchell TB; Dyer KR; Newcombe D; Salter A; Somogyi AA; Bochner F; White JM
    Br J Clin Pharmacol; 2004 Dec; 58(6):609-17. PubMed ID: 15563359
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapid detoxification from opioid dependence under general anaesthesia versus standard methadone tapering: abstinence rates and withdrawal distress experiences.
    Krabbe PF; Koning JP; Heinen N; Laheij RJ; van Cauter RM; De Jong CA
    Addict Biol; 2003 Sep; 8(3):351-8. PubMed ID: 13129838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methadone withdrawal psychosis.
    Levinson I; Galynker II; Rosenthal RN
    J Clin Psychiatry; 1995 Feb; 56(2):73-6. PubMed ID: 7852256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exploring the relationship between perceived inter-dose opioid withdrawal and patient characteristics in methadone maintenance treatment.
    Elkader AK; Brands B; Callaghan R; Sproule BA
    Drug Alcohol Depend; 2009 Dec; 105(3):209-14. PubMed ID: 19713051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medical mismanagement in public methadone programs.
    Blansfield HN
    Conn Med; 1994 Mar; 58(3):161-4. PubMed ID: 8039380
    [No Abstract]   [Full Text] [Related]  

  • 12. Withdrawal from heroin and methadone.
    Travers R
    Br J Psychiatry; 1991 Oct; 159():582-3. PubMed ID: 1751876
    [No Abstract]   [Full Text] [Related]  

  • 13. Slow-release oral morphine for maintenance treatment of opioid addicts intolerant to methadone or with inadequate withdrawal suppression.
    Kastelic A; Dubajic G; Strbad E
    Addiction; 2008 Nov; 103(11):1837-46. PubMed ID: 19032534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Importance of gabapentin dose in treatment of opioid withdrawal.
    Salehi M; Kheirabadi GR; Maracy MR; Ranjkesh M
    J Clin Psychopharmacol; 2011 Oct; 31(5):593-6. PubMed ID: 21869694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Static and dynamic pupillometry for determination of the course of gradual detoxification of opiate-addicted patients.
    Grünberger J; Linzmayer L; Fodor G; Presslich O; Praitner M; Loimer N
    Eur Arch Psychiatry Clin Neurosci; 1990; 240(2):109-12. PubMed ID: 2149649
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment and management of opioid withdrawal symptoms in buprenorphine-dependent subjects.
    San L; Camí J; Fernández T; Ollé JM; Peri JM; Torrens M
    Br J Addict; 1992 Jan; 87(1):55-62. PubMed ID: 1311974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Naltrexone-assisted rapid methadone discontinuation: a pilot study.
    Camarasa X; Khazaal Y; Besson J; Zullino DF
    Eur Addict Res; 2007; 13(1):20-4. PubMed ID: 17172775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outpatient versus inpatient opioid detoxification: a randomized controlled trial.
    Day E; Strang J
    J Subst Abuse Treat; 2011 Jan; 40(1):56-66. PubMed ID: 21036514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two new rating scales for opiate withdrawal.
    Handelsman L; Cochrane KJ; Aronson MJ; Ness R; Rubinstein KJ; Kanof PD
    Am J Drug Alcohol Abuse; 1987; 13(3):293-308. PubMed ID: 3687892
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Major depressive disorder and patient satisfaction in relation to methadone pharmacokinetics and pharmacodynamics in stabilized methadone maintenance patients.
    Elkader AK; Brands B; Dunn E; Selby P; Sproule BA
    J Clin Psychopharmacol; 2009 Feb; 29(1):77-81. PubMed ID: 19142113
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.